Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sharda Cropchem Limited (SHARDACROP.NS)
Mumbai, IN
Founded in 1987 and headquartered in Mumbai, India, Sharda Cropchem Limited is a prominent global supplier of crop protection chemicals. The company offers an extensive portfolio of agrochemical products, including various formulations and generic active ingredients such as insecticides, fungicides, herbicides, plant growth regulators, veterinary drugs, fumigants, and rodenticides, with specific compounds like metalaxyl, propiconazole, and pendimethalin also available. Beyond agriculture, Sharda Cropchem also manufactures biocides. Expanding its industrial reach, the company produces a diverse range of conveyor belts—including textile ply, steel cord, chevron, and sidewall types—designed for demanding applications in sectors like mining, steel production, quarries, grain silos, cement manufacturing, and port operations. Additionally, Sharda Cropchem supplies organic and inorganic chemicals vital for water treatment, food and beverage processing, and various other industrial applications. Its offerings further extend to dyes, dye intermediates, and a variety of general chemicals.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.99% | -14.18% | -12.62% | -22.58% | +21.91% | +10.87% | +53.70% | +96.15% | +186.01% | +222.61% | +319.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+21.9% ★ Q1'26: +12.9% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+123.7% ★ Q1'26: +56.5% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+8.0% Q1'26: +29.3% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+13.8% ★ Q1'26: +21.3% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+22.6% ★ Q1'26: +52.0% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 6 Rev. Ana. 6 EPS Ana. |
Mar 2027 6 Rev. Ana. 4 EPS Ana. |
Mar 2028 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.61B
est: 10.61B (+0.0%)
|
12.19B
est: 10.97B (+11.0%)
|
13.90B
est: 14.02B (-0.9%)
|
17.07B
est: 17.13B (-0.4%)
|
19.96B
est: 20.90B (-4.5%)
|
19.98B
est: 18.08B (+10.5%)
|
23.91B
est: 22.60B (+5.8%)
|
35.76B
est: 34.25B (+4.4%)
|
40.45B
est: 41.99B (-3.7%)
|
31.61B
est: 33.10B (-4.5%)
|
43.20B
est: 39.76B (+8.6%)
|
52.79B
51.74B – 53.46B
+32.8% YoY
|
59.96B
59.19B – 60.78B
+13.6% YoY
|
67.53B
65.04B – 70.13B
+12.6% YoY
|
| EBITDA |
2.08B
est: 1.77B (+17.9%)
|
3.04B
est: 2.04B (+49.3%)
|
3.37B
est: 3.84B (-12.1%)
|
3.71B
est: 3.83B (-3.4%)
|
3.54B
est: 4.66B (-24.0%)
|
3.38B
est: 2.96B (+14.3%)
|
4.96B
est: 3.62B (+37.0%)
|
7.25B
est: 3.96B (+82.9%)
|
6.99B
est: 4.41B (+58.6%)
|
3.43B
est: 5.46B (-37.3%)
|
6.13B
est: 6.55B (-6.3%)
|
8.71B
8.54B – 8.82B
+33.1% YoY
|
9.90B
9.77B – 10.03B
+13.6% YoY
|
11.15B
10.74B – 11.58B
+12.6% YoY
|
| EBIT |
1.77B
est: 1.03B (+72.0%)
|
2.62B
est: 1.76B (+49.1%)
|
2.72B
est: 3.09B (-12.0%)
|
2.92B
est: 3.02B (-3.2%)
|
2.43B
est: 3.60B (-32.3%)
|
1.86B
est: 2.43B (-23.4%)
|
3.26B
est: 2.55B (+27.8%)
|
4.79B
est: 2.79B (+71.9%)
|
4.51B
est: 3.10B (+45.4%)
|
754.91M
est: 3.22B (-76.5%)
|
3.39B
est: 3.85B (-12.0%)
|
5.13B
5.03B – 5.19B
+33.1% YoY
|
5.82B
5.75B – 5.90B
+13.6% YoY
|
6.56B
6.32B – 6.81B
+12.6% YoY
|
| Net Income |
1.23B
est: 1.31B (-6.0%)
|
1.75B
est: 1.28B (+36.7%)
|
1.90B
est: 2.27B (-16.0%)
|
1.91B
est: 2.22B (-14.2%)
|
1.76B
est: 2.42B (-27.2%)
|
1.65B
est: 1.58B (+4.4%)
|
2.29B
est: 1.95B (+17.3%)
|
3.49B
est: 2.14B (+63.2%)
|
3.42B
est: 2.38B (+43.7%)
|
318.83M
est: 1.48B (-78.4%)
|
3.04B
est: 2.78B (+9.5%)
|
5.62B
4.87B – 6.36B
+102.1% YoY
|
6.77B
5.55B – 6.97B
+20.5% YoY
|
7.79B
5.98B – 8.46B
+15.1% YoY
|
| SGA |
925.29M
est: 816.78M (+13.3%)
|
927.59M
est: 1.47B (-36.9%)
|
1.18B
est: 1.86B (-36.5%)
|
1.32B
est: 1.93B (-31.3%)
|
1.51B
est: 2.32B (-34.7%)
|
1.60B
est: 1.92B (-17.0%)
|
2.17B
est: 2.77B (-21.8%)
|
2.51B
est: 3.03B (-17.4%)
|
3.36B
est: 3.37B (-0.4%)
|
3.88B
est: 2.92B (+32.8%)
|
796.63M
est: 3.50B (-77.2%)
|
4.66B
4.56B – 4.72B
+33.1% YoY
|
5.29B
5.22B – 5.36B
+13.6% YoY
|
5.96B
5.74B – 6.19B
+12.6% YoY
|
| EPS |
13.63
est: 14.50 (-6.0%)
|
19.41
est: 14.00 (+38.6%)
|
21.11
est: 23.20 (-9.0%)
|
21.14
est: 23.80 (-11.2%)
|
19.55
est: 23.10 (-15.4%)
|
18.25
est: 16.10 (+13.4%)
|
25.40
est: 23.63 (+7.5%)
|
38.71
est: 36.53 (+6.0%)
|
37.90
est: 37.79 (+0.3%)
|
3.53
est: 16.38 (-78.4%)
|
33.74
est: 30.77 (+9.6%)
|
65.48
53.96 – 70.53
+112.8% YoY
|
72.80
61.50 – 77.30
+11.2% YoY
|
82.28
66.30 – 93.80
+13.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ramprakash Vilasrai Bubna | Founder, Chairman & MD | 44M | male |
| Ashish Ramprakash Bubna | Founder & Whole-Time Director | 33M | male |
| Manish Ramprakash Bubna | Founder & Whole-Time Director | 33M | male |
| Sharda Ramprakash Bubna | Founder & Whole-Time Director | 33M | female |
| Jetkin Navinchan Gudhka | Company Secretary & Compliance Officer | — | male |
| Shailesh Anant Mehendale | Chief Financial Officer | — | male |
| Amol Prabhughate | Manager of Human Resources | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SHARDACROP.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
